ArticleProceedings of the National Academy of Sciences of the United States of America2009

Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency.

Paolo Ingallinella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.